Anti-CO6A1/ COL6A1/ BTHLM1 functional antibody

Anti-CO6A1/ COL6A1/ BTHLM1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to COL6A1/COL6A1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0111-Ab-1/ GM-Tg-hg-SE0111-Ab-2Anti-Human COL6A1 monoclonal antibodyHuman
GM-Tg-rg-SE0111-Ab-1/ GM-Tg-rg-SE0111-Ab-2Anti-Rat COL6A1 monoclonal antibodyRat
GM-Tg-mg-SE0111-Ab-1/ GM-Tg-mg-SE0111-Ab-2Anti-Mouse COL6A1 monoclonal antibodyMouse
GM-Tg-cynog-SE0111-Ab-1/ GM-Tg-cynog-SE0111-Ab-2Anti-Cynomolgus/ Rhesus macaque COL6A1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0111-Ab-1/ GM-Tg-felg-SE0111-Ab-2Anti-Feline COL6A1 monoclonal antibodyFeline
GM-Tg-cang-SE0111-Ab-1/ GM-Tg-cang-SE0111-Ab-2Anti-Canine COL6A1 monoclonal antibodyCanine
GM-Tg-bovg-SE0111-Ab-1/ GM-Tg-bovg-SE0111-Ab-2Anti-Bovine COL6A1 monoclonal antibodyBovine
GM-Tg-equg-SE0111-Ab-1/ GM-Tg-equg-SE0111-Ab-2Anti-Equine COL6A1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0111-Ab-1/ GM-Tg-hg-SE0111-Ab-2; GM-Tg-rg-SE0111-Ab-1/ GM-Tg-rg-SE0111-Ab-2;
GM-Tg-mg-SE0111-Ab-1/ GM-Tg-mg-SE0111-Ab-2; GM-Tg-cynog-SE0111-Ab-1/ GM-Tg-cynog-SE0111-Ab-2;
GM-Tg-felg-SE0111-Ab-1/ GM-Tg-felg-SE0111-Ab-2; GM-Tg-cang-SE0111-Ab-1/ GM-Tg-cang-SE0111-Ab-2;
GM-Tg-bovg-SE0111-Ab-1/ GM-Tg-bovg-SE0111-Ab-2; GM-Tg-equg-SE0111-Ab-1/ GM-Tg-equg-SE0111-Ab-2
Products NameAnti-COL6A1 monoclonal antibody
Formatmab
Target NameCOL6A1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-COL6A1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0111-Ag-1Recombinant multi-species CO6A1/ COL6A1/ BTHLM1 protein


    Target information

    Target IDGM-SE0111
    Target NameCOL6A1
    Gene ID1291,12833,294337,721855,403668,101081156,511422,100050035
    Gene Symbol and SynonymsBTHLM1,Col6a-1,COL6A1,OPLL,RGD1565398,UCHMD1
    Uniprot AccessionP12109
    Uniprot Entry NameCO6A1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000142156
    Target ClassificationN/A

    The target: COL6A1, gene name: COL6A1, also named as BTHLM1, OPLL, UCHMD1. The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.